Abstract
The radiochemical separation of n.c.a. arsenic on its own or for radio-labelling purposes usually involves the issue of reducing arsenic(V). Numerous approaches for reducing pentavalent arsenic have been examined. A novel HPLC method has also been presented for accessing the efficiency of the reduction in terms of *As(III)/*As(V). Labelling with trivalent radioarsenic seems to be a promising research field to access new radiopharmaceuticals, for example, using arsenic as a surrogate for phosphorus. Moreover, as a model system, the labelling reaction of *As(III) with dihydrolipoic acid has been systematically optimized.
Original language | English (US) |
---|---|
Pages (from-to) | 75-82 |
Number of pages | 8 |
Journal | Applied Radiation and Isotopes |
Volume | 149 |
DOIs | |
State | Published - Jul 2019 |
Bibliographical note
Publisher Copyright:© 2019